https://pubmed.ncbi.nlm.nih.gov/21912653/
Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular...
Hh pathway activation promotes liver fibrosis and hepatocarcinogenesis, and inhibiting Hh signaling safely reverses both processes even when fibrosis and HCC...
hedgehog signalingliver fibrosisantagonistpromotesregression
https://boris-portal.unibe.ch/entities/publication/09f64162-a43b-44b3-bde6-40ce57ad8377
CT detection of liver fibrosis in a potentially reversible pre-cirrhotic stage
liver fibrosisin a
https://education.rsna.org/Listing/Liver-Fibrosis-Fat-and-Iron-Evaluation-with-MRI-and-Fibrosis-and-Fat-Evaluation-with-US-A-Practical-Guide-for-Radiologists-June-2023-8647
Liver Fibrosis, Fat, and Iron Evaluation with MRI and Fibrosis and Fat Evaluation with US: A...
liver fibrosisfatironevaluationmri
https://research.polyu.edu.hk/en/publications/evaluation-of-liver-fibrosis-by-investigation-of-hepatic-parenchy/
Evaluation of liver fibrosis by investigation of hepatic parenchymal perfusion using...
liver fibrosisevaluationinvestigationhepaticperfusion
https://www.health-holland.com/project/2014/resolving-fibrosis-in-non-alcoholic-steatohepatitis
Resolving liver fibrosis with nutritional and therapeutic interventions. | Health~Holland
Non-alcoholic fatty liver disease (NAFLD) ranges from simple steatosis to non-alcoholic steatohepatitis (NASH), leading to fibrosis and potentially cirrhosis,...
liver fibrosistherapeutic interventionsnutritionalhealthholland
https://histoindex.com/blog/navigating-liver-fibrosis-imaging/
Navigating Liver Fibrosis: Innovations in Imaging and Detection
Aug 26, 2024 - The landscape of liver fibrosis imaging and diagnosis is rapidly improving, offering new hope for patients and clinicians alike.
liver fibrosisin imagingnavigatinginnovationsdetection
https://avesis.anadolu.edu.tr/yayin/d4706e0e-bf71-48f4-a61b-f961e94d595b/chronic-liver-fibrosis-induction-in-aging-causes-significant-ultra-structural-deterioration-in-liver-and-alteration-on-immune-response-gene-expressions-in-liver-spleen-axis
Chronic liver fibrosis induction in aging causes significant ultra-structural deterioration in...
liver fibrosischronicinduction
https://encyclopedia.pub/entry/7680
Renin-Angiotensin System in Liver Fibrosis | Encyclopedia MDPI
Encyclopedia is a user-generated content hub aiming to provide a comprehensive record for scientific developments. All content free to post, read, share and...
liver fibrosisreninangiotensinsystemencyclopedia
https://www.secondmedic.com/lab/metropolis-diagnostics/fibrometer-virus-liver-fibrosis-profile-for-walkin-patients-only
Book Fibrometer Virus (Liver fibrosis Profile For Walkin Patients Only) Pac
Book Fibrometer Virus (Liver fibrosis Profile For Walkin Patients Only) Package by Metropolis for Rs 4885 at SecondMedic, free doctor consultation with every pa
liver fibrosispatients onlybookvirus
https://vegastemcell.com/articles/investigating-ways-to-advance-clinical-liver-fibrosis-trials-in-regenerative-medicine-thailand-therapeutics/
Investigating ways to advance clinical Liver fibrosis trials in regenerative medicine Thailand...
Apr 28, 2026 - for Liver fibrosis trials through regenerative medicine Thailand to manage chronic liver fibrosis. Researchers
ways toliver fibrosis
https://www.siemens-healthineers.com/en-sa/laboratory-diagnostics/assays-by-diseases-conditions/liver-disease
Liver Fibrosis Assays
Improve the assessment of NAFLD/NASH and chronic liver disease in patients who are at risk of disease progression
liver fibrosisassays
https://testdirectory.questdiagnostics.com/test/test-guides/TS_ELF/enhanced-liver-fibrosis-elf-score
Enhanced Liver Fibrosis (ELF) Score | Test Summary | Quest Diagnostics
This test is used to assess the likelihood that nonalcoholic steatohepatitis (NASH) will progress to cirrhosis and liver-related clinical events.
liver fibrosisenhancedelfscoretest
https://medicaltourismtoday.in/tag/liver-fibrosis-treatment/
liver fibrosis treatment
liver fibrosistreatment
https://scholar.xjtu.edu.cn/en/publications/gaudichaudione-h-ameliorates-liver-fibrosis-and-inflammation-by-t/
Gaudichaudione H ameliorates liver fibrosis and inflammation by targeting NRF2 signaling pathway -...
liver fibrosis
https://www.sciencedaily.com/releases/2023/11/231116140941.htm
Hormones have the potential to treat liver fibrosis | ScienceDaily
Researchers have discovered previously unknown changes in a specific type of liver cells, potentially opening avenues for a new treatment for liver fibrosis, a...
the potentialliver fibrosishormonestreatsciencedaily
https://nbscience.com/mesenchymal-stem-cells-stunning-solution-for-liver-fibrosis-reversal/
Mesenchymal Stem Cells: Stunning Solution for Liver Fibrosis Reversal | Stem Cell Therapy &...
Mar 5, 2026 - Mesenchymal Stem Cells: A Stunning Solution for Liver Fibrosis Reversal Liver fibrosis, a condition characterized by excessive accumulation of extracellular...
mesenchymal stem cellssolution forliver fibrosisstunning
https://www.siemens-healthineers.com/hr/laboratory-diagnostics/assays-by-diseases-conditions/liver-disease
Liver Fibrosis Assays - Siemens Healthineers Croatia
Improve the assessment of NAFLD/NASH and chronic liver disease in patients who are at risk of disease progression
liver fibrosissiemens healthineersassayscroatia
https://air.unipr.it/handle/11381/2867246
Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of...
https://www.elsevier.es/en-revista-annals-hepatology-16-estadisticas-the-preoperative-fibrosis-score-4-S1665268119303503
The preoperative fibrosis score 4 predicts posthepatectomy liver failure in patients with...
https://www.southampton.ac.uk/research/projects/breen-wmr-purchase-of-software-research-licence-to-investigate-liver-iron-fat
Breen - WMR - Purchase of software research licence to investigate liver, iron, fat and fibrosis...
Breen - WMR - Purchase of software research licence to investigate liver, iron, fat and fibrosis quantification.
https://pure.jbnu.ac.kr/en/publications/histone-deacetylase-8-inhibition-alleviates-cholestatic-liver-inj-4/
Histone deacetylase 8 inhibition alleviates cholestatic liver injury and fibrosis - JBNU...
histone deacetylaseinhibition
https://scholars.mssm.edu/en/publications/comparison-of-blood-based-liver-fibrosis-scores-in-the-mount-sina/
Comparison of blood-based liver fibrosis scores in the Mount Sinai Health System, MASLD Registry,...
https://www.siemens-healthineers.com/en-ie/laboratory-diagnostics/assays-by-diseases-conditions/webinars/non-invasive-assessment-liver-fibrosis-chronic-liver-diseases
New webinar: Non-invasive Assessment of Liver Fibrosis in Chronic Liver Diseases - Siemens...
Assess the Risk of NAFLD/NASH Progression with a Simple Blood Test
new webinarnon invasive
https://pubmed.ncbi.nlm.nih.gov/37532736/
Gas6 in chronic liver disease-a novel blood-based biomarker for liver fibrosis
The expression of the receptor tyrosine kinase Axl and its cleavage product soluble Axl (sAxl) is increased in liver fibrosis, cirrhosis, and hepatocellular...
chronic liver disease
https://nsft.sbmu.ac.ir/article-1-2008-en.html
Effect of Ginger Supplementation on Liver Enzymes Hepatic Fibrosis and Steatosis in Nonalcoholic...
Background and Objectives: Non-alcoholic fatty liver disease is one of the most common chronic liver diseases thorough the world. The pathogenesis of...
https://repository.li.mahidol.ac.th/entities/publication/db237816-b3f3-4237-9bdf-a43bff3d480e
The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An...
Information on the long-term prognosis of nonalcoholic fatty liver disease (NAFLD) is limited. We sought to describe the long-term morbidity and mortality of...
the natural history
https://cemm.at/research/groups/adjunct-groups/thomas-reiberger/cd-lab-for-portal-hypertension-and-fibrosis-in-liver-disease
Thomas Reiberger CD Lab for Portal Hypertension and Fibrosis in Liver Disease
CD Lab for Portal Hypertension and Fibrosis in Liver Disease
portal hypertension
https://sciencemission.com/Lack-of-PCK1-in-hepatic-stellate-cells
Lack of PCK1 in hepatic stellate cells causes liver fibrosis by fueling tricarboxylic acid cycle...
https://pubmed.ncbi.nlm.nih.gov/41540395/
Tofogliflozin attenuates liver steatosis and fibrosis in non-diabetic non-alcoholic steatohepatitis...
Tofo may be a potential candidate for inhibiting liver steatosis and fibrosis via an alternative pathway, unlike glucose metabolism, in NAFLD patients without...
liver
https://pubmed.ncbi.nlm.nih.gov/31213776/
Salvianolic acid A attenuates CCl4-induced liver fibrosis by regulating the PI3K/AKT/mTOR,...
https://pure.psu.edu/en/publications/does-weight-history-affect-fibrosis-in-the-setting-of-chronic-liv/
Does weight history affect fibrosis in the setting of chronic liver disease? - Penn State
https://www.elsevier.es/en-revista-annals-hepatology-16-articulo-the-preoperative-fibrosis-score-4-S1665268119303503
The preoperative fibrosis score 4 predicts posthepatectomy liver failure in patients with...
Introduction and ObjectivesThe fibrosis score 4 (FIB-4) has been identified as a biochemical
https://www.bioworld.com/articles/694093-inhibition-of-pyrimidine-catabolism-by-targeting-hsd17b13-protects-against-liver-fibrosis-in-nafld?v=preview
Inhibition of pyrimidine catabolism by targeting HSD17B13 protects against liver fibrosis in NAFLD...
Researchers from Yale School of Medicine, along with Helsinki University Hospital and University of Helsinki, have reported data from a study that aimed to...
https://www.rug.nl/about-ug/latest-news/news/archief2014/promoties/promotie-dhr.-a.-ur-rehman_-abc-transporters-as-therapeutic-targets-for-liver-fibrosis-?lang=en
PhD ceremony Mr. A. ur Rehman: ABC transporters as therapeutic targets for liver fibrosis | News |...
Mar 13, 2020 - PhD ceremony: Mr. A. ur Rehman Dissertation: ABC transporters as therapeutic targets for liver fibrosis Promotor(s): prof. K.N. Faber, prof. A.J....
https://dirjournal.org/articles/fat-and-iron-corrected-adc-to-assess-liver-fibrosis-in-patients-with-chronic-hepatitis-b/doi/dir.2021.21471
Fat- and iron-corrected ADC to assess liver fibrosis in patients with chronic hepatitis B -...
Fat- and iron-corrected ADC to assess liver fibrosis in patients with chronic hepatitis B - Diagnostic and Interventional Radiology
https://www.clinsurggroup.com/gjmccr/article/view/GJMCCR-7-189/pdf
View of The Diagnostic value of FibroScan for the degree of liver fibrosis in patients with...
https://scholars.mssm.edu/en/publications/liver-fibrosis-and-hepatic-stellate-cells-2/
Liver fibrosis and hepatic stellate cells - Icahn School of Medicine at Mount Sinai
school of medicine
https://events.manchester.ac.uk/event/event:a45-i9zkaxbi-3d69vm/mechanisms-underlying-ecm-deposition-and-function-in-liver-fibrosis
Mechanisms underlying ECM deposition and function in liver fibrosis | Events at The University of...
https://research.hub.ku.edu.tr/entities/publication/31489852-a633-40b4-bd7d-4a22db2fe55f
A proof-of-concept for epigenetic therapy of tissue fibrosis: inhibition of liver fibrosis...
The progression of fibrosis in chronic liver disease is dependent upon hepatic stellate cells (HSCs) transdifferentiating to a myofibroblast-like phenotype....
proof of concept
https://publires.unicatt.it/en/publications/exploratory-study-of-extracellular-matrix-biomarkers-for-non-inva/
Exploratory study of extracellular matrix biomarkers for non-invasive liver fibrosis staging: A...
https://www.e-enm.org/journal/view.php?number=2382
Performance of Simple Fibrosis Score in Non-Alcoholic Fatty Liver Disease with and without Type 2...
https://www.pocn.com/pathogenic-role-of-pcpe-1-in-liver-fibrosis-linked-to-brown-adipose-tissue-in-obesity/
Pathogenic Role of PCPE-1 in Liver Fibrosis Linked to Brown Adipose Tissue in Obesity - POCN
Oct 25, 2024 - Excessive calorie intake triggers chronic inflammation in visceral adipose tissue, [...]
https://iris.cnr.it/handle/20.500.14243/499163
Non-invasive tools for detection of liver disease in children and adolescents with cystic fibrosis
https://practicalgastro.com/2014/06/14/infected-microabscesses-in-congenital-hepatic-fibrosis-and-subsequent-treatment-with-liver-transplantation/
Infected Microabscesses In Congenital Hepatic Fibrosis and Subsequent Treatment With Liver...
Nov 22, 2019 - INTRODUCTION Congenital hepatic fibrosis (CHF) is a developmental malformation of the hepatic ductal plate with associated renal disease, most commonly...
infectedcongenitalhepatic
https://sandiegopsychiatrist.com/does-drinking-alcohol-increase-risk-of-getting-cancer/liver-damage-such-as-fatty-liver-fibrosis-cirrhosis-and-liver-cancer-3d-illustration/
Liver damage such as Fatty liver, Fibrosis, Cirrhosis, and Liver cancer. 3d illustration -...
Sep 24, 2025 - Liver damage such as Fatty liver, Fibrosis, Cirrhosis, and Liver cancer. 3d illustration
liver damagesuch asfatty
https://ouci.dntb.gov.ua/en/works/l11Gbado/
Liver targeted nanomedicine for treatment of fibrosis and hepatocellular carcinoma: Emerging...
hepatocellular carcinomalivertargetednanomedicinetreatment
https://www.oaepublish.com/articles/mtod.2024.38
Dysregulation of sphingolipid metabolism in liver fibrosis
The dysregulation of sphingolipid metabolism emerges as a pivotal factor in the development and progression of liver fibrosis, a condition marked by the...
dysregulationmetabolismliverfibrosis
https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2022.1059675/full
Frontiers | Associations of phthalates with NAFLD and liver fibrosis: A nationally representative...
Although phthalates are common environmental pollutants, few studies have focused on the relationship of phthalate exposure with non-alcoholic fatty liver di...
https://gastrores.org/index.php/Gastrores/article/view/246
Clinical Benefits of Biochemical Markers of Fibrosis in Egyptian Children With Chronic Liver...
Clinical Benefits of Biochemical Markers of Fibrosis in Egyptian Children With Chronic Liver Diseases
clinical benefits
https://scholars.uthscsa.edu/en/publications/non-alcoholic-fatty-liver-disease-liver-fibrosis-score-and-cognit/
Non-alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle-aged...
fatty liver disease
https://scholars.houstonmethodist.org/en/publications/a-phase-3-randomized-controlled-trial-of-resmetirom-in-nash-with-/
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis - Houston...
https://scholars.lib.ntu.edu.tw/entities/publication/79b7b67a-227e-4980-8240-e87fa91921ec
Glycopeptide profiling as a tool to discover novel markers of disease progression in liver fibrosis